Form 4 holding
President & CEO, Director
Trevi Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 213,313
- Estimated value
- $1,403,365
- Report date
- 21 Mar 2025
- Price
- $6.58
- Ownership
- Direct
Jennifer L. Good - President & CEO, Director at Trevi Therapeutics, Inc.
Issuer-level insider activity
- Role
- President & CEO, Director
- Issuer ticker
- TRVI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jennifer L. Good since 13 Sep 2025
Reported holdings for Jennifer L. Good in Trevi Therapeutics, Inc.
Form 4 holding
President & CEO, Director
Trevi Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 675,000
- Estimated value
- Report date
- 19 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President & CEO, Director
Trevi Therapeutics, Inc.
- Security class
- Performance Stock Option (right to buy)
- Shares / value
- 156,400
- Estimated value
- Report date
- 31 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jennifer L. Good in Trevi Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.